Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Frontline Education Launches Absence Community to Support K-12 Schools for Back-to-School Success
-
ORBCOMM enhances its managed network offering with next-generation OGx IoT service, paving the way for accelerated industrial digitalization
-
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association
-
Good Rāz Recognized As “Vitamin Product Of The Year” In 2024 Mindful Awards Program
-
Reunion Gold Provides a Reminder Regarding Expiry of Warrants
-
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Joe Onyero, CEO of Bebuzee Inc.
-
Erasca Initiates SEACRAFT-2 Pivotal Phase 3 Trial Evaluating Naporafenib Plus Trametinib in Patients with NRAS-Mutant Melanoma
-
Winshear Commences Construction of Drill Roads and Field Camp Ahead of Its Maiden 1,600m Drill Program at the Gaban Gold Project in Peru
-
WalkMe Discovers Workplace AI SOS: We Need Help Along The Way!
-
Jessup University Welcomes New Faculty Dr. Eduardo Romo Whose New Study Solidifies Gut-Brain Link in Alzheimer’s Disease
-
WalkMe Unveils WalkMe(X): The Premier Contextual AI Copilot Designed For The Enterprise
-
Arq Secures Second Contract for its Granular Activated Carbon (GAC) Facility
-
FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024
-
Prosper Gold Corp. Mobilizes ZTEM Survey crew to Cyprus Project
-
RTI Connext Drive Achieves ASPICE Capability Level 1 to Improve Development Processes for the Automotive Industry
-
Jess King Partners With Fabrik to Launch ‘On The Record’
-
Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology
-
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)
-
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
-
BairesDev CEO Nacho De Marco Wins Ernst & Young’s Entrepreneur Of The Year® 2024 Bay Area Award
-
CorMedix Inc. Receives FDA Feedback on Potential Label Expansion
-
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
-
authID and Syntrove Announce OEM Partnership for authID’s Secure Biometric Identity Services
-
Google Joins the AR Alliance for Augmented Reality Wearable Devices
-
Jeff Browe Appointed CEO of Bastion Agency, USA
-
First Onsite expands in Virginia with new branch in Roanoke
-
SeekOut Introduces CHRO Council
-
Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
-
CORRECTION -- Apollo Tactical Income Fund Inc. Declares June 2024 Monthly Distribution of $0.144 Per Share
-
CORRECTION -- Apollo Senior Floating Rate Fund Inc. Declares June 2024 Monthly Distribution of $0.140 Per Share
-
Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting
-
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population Extension Cohort in a Broad Wet AMD Population at ASRS and Host a Corporate Webcast
-
Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial
-
Genetic Technologies Expands Operational Capacity in North America
-
Salsify Names Piyush Chaudhari as New CEO
-
Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
-
Bitdeer to Participate in the 16th Annual CEO Investor Summit 2024
-
Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024
-
authID and Syntrove Announce OEM Partnership for authID’s Secure Biometric Identity Services
-
Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024
-
Zyter|TruCare Recognized as a Trailblazer in Member Engagement by Everest Group
-
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
-
BairesDev CEO Nacho De Marco Wins Ernst & Young’s Entrepreneur Of The Year® 2024 Bay Area Award
-
GoHealth to Present at the Noble Capital Markets Consumer, Communications, Media, and Technology Emerging Growth Virtual Equity Conference
-
Powerdyne International Inc. Begins Preliminary Talks with an AI Motor Manufacturer for a Potential Acquisition or Merger
-
kama.ai Delivers Release 3 of its Responsible Agentic AI Platform
-
Red Gold Modernizes Dock Scheduling, Transportation Management, and LTL Process with Loadsmart
-
CDM Smith welcomes trio of strategic hires to solve top water challenges
-
COMSovereign and Intelligent Waves Partner for Secure 5G, Drone Platforms and Software-as-a-Service Solutions Sales to the Government and DoD Markets
-
FDH Aero Establishes FDH Defense Aftermarket Division
